 Proliferation." J Pharmacol Exp Ther 2016; 357:36-44.
- Wei Q, et al. "Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses." Purinergic Signal 2013; 9:271-80.
- Li S, Huang S, Peng S. "The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role." Int J Oncol 2005; 27:1329-39.